Pharmacological Enhancement of Memory and Executive Functioning in Laboratory Animals

被引:82
作者
Floresco, Stan B. [1 ,2 ]
Jentsch, James D. [3 ,4 ]
机构
[1] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada
[2] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z4, Canada
[3] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
关键词
cognitive enhancers; memory modulation; attention; working memory; response inhibition; extinction; behavioral flexibility; REACTION-TIME-TASK; MEDIAL PREFRONTAL CORTEX; NICOTINIC ACETYLCHOLINE-RECEPTOR; SPATIAL WORKING-MEMORY; METABOTROPIC GLUTAMATE RECEPTORS; IMPROVES COGNITIVE PERFORMANCE; PHENCYCLIDINE-INDUCED DEFICITS; DOPAMINE D-1 RECEPTOR; SHORT-TERM-MEMORY; INDUCED ATTENTIONAL ENHANCEMENT;
D O I
10.1038/npp.2010.158
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Investigating how different pharmacological compounds may enhance learning, memory, and higher-order cognitive functions in laboratory animals is the first critical step toward the development of cognitive enhancers that may be used to ameliorate impairments in these functions in patients suffering from neuropsychiatric disorders. Rather than focus on one aspect of cognition, or class of drug, in this review we provide a broad overview of how distinct classes of pharmacological compounds may enhance different types of memory and executive functioning, particularly those mediated by the prefrontal cortex. These include recognition memory, attention, working memory, and different components of behavioral flexibility. A key emphasis is placed on comparing and contrasting the effects of certain drugs on different cognitive and mnemonic functions, highlighting methodological issues associated with this type of research, tasks used to investigate these functions, and avenues for future research. Viewed collectively, studies of the neuropharmacological basis of cognition in rodents and non-human primates have identified targets that will hopefully open new avenues for the treatment of cognitive disabilities in persons affected by mental disorders. Neuropsychopharmacology Reviews (2011) 36, 227-250; doi: 10.1038/npp.2010.158; published online 15 September 2010
引用
收藏
页码:227 / 250
页数:24
相关论文
共 335 条